The short answer
TMB-high is a biomarker result. It means a high tumor mutational burden. In some cancers, biomarker results can help guide targeted therapy, immunotherapy, or clinical trial options, but the result only matters in context.
TMB-high is a biomarker or molecular result, not a treatment decision by itself.
It can be relevant in some advanced cancers where immunotherapy is being considered.
A positive result may or may not change treatment depending on cancer type, stage, prior treatment, and available options.
Ask whether the result is from tumor testing, blood testing, inherited genetic testing, or another method.
Choose how you want to read this
The whole article, with every detail and caution.
This page is for people whose tumor testing report says "TMB-high." It explains what the result means, how it can affect treatment options, and what it does not tell you.
The short answer
TMB stands for tumor mutational burden. It counts how many mutations the cancer carries, per stretch of DNA that was tested. Labs report this as mutations per megabase, often shortened to mut/Mb. TMB-high, or TMB-H, usually means 10 or more mutations per megabase on the specific test used. NCI says this number can help show whether a type of immunotherapy called an immune checkpoint inhibitor may work for you.
Where it may be relevant
This result can be relevant in some advanced cancers, where doctors are weighing immunotherapy. Not everyone with these cancers needs, or benefits from, the same testing or treatment.
Why it can affect treatment options
Pembrolizumab, an immunotherapy drug, is FDA-approved for unresectable or metastatic TMB-high solid tumors. That means the approval is based on the TMB result, not on where the cancer started. This applies only when TMB is measured with a specific FDA-approved test, called FoundationOne CDx, using the 10 mut/Mb cutoff.
It helps to be realistic about the odds. In the trial behind this approval, 102 people with TMB-high cancer were treated with pembrolizumab. About 29% of them responded, meaning their tumors shrank or, in 4% of cases, disappeared completely. So TMB-high improves the chances of benefit. It does not guarantee benefit.
What this result does NOT tell you
A TMB-high result does not mean immunotherapy is your only good option, or even your best one. Your team weighs it alongside other results, like PD-L1 and MSI-H/dMMR status. The FDA approval names one test, so ask which test your lab used. And TMB-high does not predict which specific drug will work best. The approval described here applies to pembrolizumab specifically, tested in a specific way.
Is this urgent?
A TMB-high result is not an emergency by itself. Ask your team how soon any treatment decision is needed. If you have new or worsening symptoms, call your care team right away.
Questions to ask
- Which test and which cutoff were used to call my cancer TMB-high?
- How does TMB compare with my other biomarker results, such as PD-L1 or MSI-H/dMMR?
- Is pembrolizumab being considered because of this result, or for another reason?
- What are the realistic chances of response for someone in my situation?
Sources
Common questions
What is TMB-high?
TMB-high means a high tumor mutational burden. It is one type of result that may appear on a biomarker, molecular, genomic, or pathology report.
Can it affect treatment?
Sometimes. Certain biomarkers can point toward targeted therapy, immunotherapy, or a clinical trial, but the same result can mean different things in different cancers.
What should I ask my oncologist?
Ask whether the result is actionable for your cancer, whether a matched treatment exists, and whether a trial is relevant.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Look up more plain-language explanations for report wording.
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-07-30 what this meansLast updated: 2026-08-11Next planned review: 2027-07-30
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
Knowledge check
0 of 3 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.